Wencheng Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Wencheng Li has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Ying Shi
Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3 shared publications Bing Li
Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2 shared publications- Fuqing Zeng
Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
2 shared publications Hua-Geng Liang
Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
2 shared publicationsMing Xiong
Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2 shared publicationsWen Ju
Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
2 shared publications
Latest Publications
- 20 February 2024
- Published by SAGE Publications in Journal of Endourology
- Vol. 38 (3) , 283-289
Treating Multifocal Ureteral Strictures with Combined Techniques: 14 Cases of Initial Experience
Purpose: To evaluate the safety and feasibility of lingual mucosal graft ureteroplasty (LMGU) combined with ureteral reimplantation (UR) for repairing managing multifocal ureteral strictures (MUS). Methods: Between December 2020 and December 2022, 14 patients underwent LMGU combined with UR. Their perioperative data were collected retrospectively and analyzed. For the proximal diseased ureter, the narrow segment was incised longitudinally to open the ventral wall of ureter, and a lingual mucosal graft (LMG) was placed as an onlay graft. Meanwhile, UR was applied to treat distal ureteral strictures. Results: Of 14 patients, three (21.4%) had previously undergone a failed ureteral reconstruction. The mean (SD) proximal stricture length was 4.0 cm (1.56), distal ureteral stricture length was 4.3 cm (0.94). The mean (SD) operative time was 236 min (57), the estimated blood loss was 78 ml (41.5), and the length of postoperative stay was 6 days. One (7%) patient underwent double LMGU to treat proximal 2 segments of ureteral stricture. No open conversions and intraoperative complications occurred. With a mean follow-up of 15 months (range 6–29), the recurrence-free rate was 14/14 (100%). Conclusions: LMGU combined with UR is a feasible and effective technique for managing MUS and can be an alternative to IUR or renal autotransplantation in some selected patients with MUS.
- 20 February 2024
- Published by SAGE Publications in Journal of Endourology
- Vol. 38 (3) , 283-289
Treating Multifocal Ureteral Strictures with Combined Techniques: 14 Cases of Initial Experience
Purpose: To evaluate the safety and feasibility of lingual mucosal graft ureteroplasty (LMGU) combined with ureteral reimplantation (UR) for repairing managing multifocal ureteral strictures (MUS). Methods: Between December 2020 and December 2022, 14 patients underwent LMGU combined with UR. Their perioperative data were collected retrospectively and analyzed. For the proximal diseased ureter, the narrow segment was incised longitudinally to open the ventral wall of ureter, and a lingual mucosal graft (LMG) was placed as an onlay graft. Meanwhile, UR was applied to treat distal ureteral strictures. Results: Of 14 patients, three (21.4%) had previously undergone a failed ureteral reconstruction. The mean (SD) proximal stricture length was 4.0 cm (1.56), distal ureteral stricture length was 4.3 cm (0.94). The mean (SD) operative time was 236 min (57), the estimated blood loss was 78 ml (41.5), and the length of postoperative stay was 6 days. One (7%) patient underwent double LMGU to treat proximal 2 segments of ureteral stricture. No open conversions and intraoperative complications occurred. With a mean follow-up of 15 months (range 6–29), the recurrence-free rate was 14/14 (100%). Conclusions: LMGU combined with UR is a feasible and effective technique for managing MUS and can be an alternative to IUR or renal autotransplantation in some selected patients with MUS.
- Open Access
- 24 November 2023
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 11, 1248674
Association between N, N-diethyl-m-toluamide exposure and the odds of kidney stones in US adults: a population-based study
Background: Currently, there is limited research on the specific relationship between N, N-diethyl-m-toluamide (DEET) exposure and the odds of kidney stones. We aimed to investigate the relationship between DEET exposure and the prevalence of kidney stones.Methods: We included 7,567 qualified participants in our research from the 2007–2016 NHANES survey. We carried out three logistic regression models to explore the potential association between DEET exposure and the odds of kidney stones. Spline smoothing with generalized additive models (GAM) was utilized to assess the non-linear relationship and restricted cubic spline (RCS) curves was to determine the dose–response association. Multivariate regression models were used to conduct stratified analysis and sensitivity analysis.Results: Baseline characteristics of study participants presented the distribution of covariables. Regression analysis revealed that the odds of kidney stones were positively associated with the main metabolites of 3-diethyl-carbamoyl benzoic acid (DCBA) (log2) (OR = 1.05, 95% CI 1.02 to 1.08). The fourth quartile of urine DCBA showed a greater risk of kidney stones in the fully adjusted model (OR = 1.36, 95% CI 1.08 to 1.72). Another DEET metabolite of N, N-diethyl-3-hydroxymethylbenzamide (DHMB) was used to confirm the accuracy and stability of the results. The spline smoothing curve represented two main DEET metabolites had similar no-linear relationships and a positive trend with kidney stones proportion. RCS implied that the incidence of kidney stones rose with increasing levels of DEET exposure. High-risk groups on kidney stones were exhibited by stratified analysis under DEET exposure.Conclusion: Our study suggests that DEET exposure is positively associated with odds of kidney stones. Further investigation into the underlying processes of this association is required to guide the prevention and treatment of kidney stones.
- 24 November 2023
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 11, 1248674
Open AccessAssociation between N, N-diethyl-m-toluamide exposure and the odds of kidney stones in US adults: a population-based study
Background: Currently, there is limited research on the specific relationship between N, N-diethyl-m-toluamide (DEET) exposure and the odds of kidney stones. We aimed to investigate the relationship between DEET exposure and the prevalence of kidney stones.Methods: We included 7,567 qualified participants in our research from the 2007–2016 NHANES survey. We carried out three logistic regression models to explore the potential association between DEET exposure and the odds of kidney stones. Spline smoothing with generalized additive models (GAM) was utilized to assess the non-linear relationship and restricted cubic spline (RCS) curves was to determine the dose–response association. Multivariate regression models were used to conduct stratified analysis and sensitivity analysis.Results: Baseline characteristics of study participants presented the distribution of covariables. Regression analysis revealed that the odds of kidney stones were positively associated with the main metabolites of 3-diethyl-carbamoyl benzoic acid (DCBA) (log2) (OR = 1.05, 95% CI 1.02 to 1.08). The fourth quartile of urine DCBA showed a greater risk of kidney stones in the fully adjusted model (OR = 1.36, 95% CI 1.08 to 1.72). Another DEET metabolite of N, N-diethyl-3-hydroxymethylbenzamide (DHMB) was used to confirm the accuracy and stability of the results. The spline smoothing curve represented two main DEET metabolites had similar no-linear relationships and a positive trend with kidney stones proportion. RCS implied that the incidence of kidney stones rose with increasing levels of DEET exposure. High-risk groups on kidney stones were exhibited by stratified analysis under DEET exposure.Conclusion: Our study suggests that DEET exposure is positively associated with odds of kidney stones. Further investigation into the underlying processes of this association is required to guide the prevention and treatment of kidney stones.
- Open Access
- 1 April 2023
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 12 (4) , 533-548
Comprehensive analysis of alternative polyadenylation regulators of CTLA4 and immune infiltration in clear cell renal cell carcinoma
Original Article Comprehensive analysis of alternative polyadenylation regulators of CTLA4 and immune infiltration in clear cell renal cell carcinoma Menghao Zhou, Wulin Long, Ming Xiong, Futian Zhang, Liang Chen, Jiawei Chen, Zili Pang, Teng Hou, Wencheng Li
- 1 April 2023
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 12 (4) , 533-548
Open AccessComprehensive analysis of alternative polyadenylation regulators of CTLA4 and immune infiltration in clear cell renal cell carcinoma
Original Article Comprehensive analysis of alternative polyadenylation regulators of CTLA4 and immune infiltration in clear cell renal cell carcinoma Menghao Zhou, Wulin Long, Ming Xiong, Futian Zhang, Liang Chen, Jiawei Chen, Zili Pang, Teng Hou, Wencheng Li
- Open Access
- 15 August 2022
- Published by Springer Nature in Molecular Cytogenetics
- Vol. 15 (1) , 1-5
Prenatal diagnosis and genetic counseling of an inherited unbalanced chromosome abnormalities in a Chinese family
Unbalanced chromosome abnormalities (UBCA) are either gains or losses or large genomic regions, but the affected person is not or only minimally clinically affected. Copy number variants (CNVs) are an important source of normal and pathogenic genome variations. CNVs and UBCA identified in prenatal cases need careful considerations and correct interpretation if those are harmless or harmful variants from the norm. A 25-year-old, gravida 1, para 0, woman underwent amniocentesis at 18 weeks of gestation because the noninvasive prenatal testing (NIPT) results revealed a 6.8 Mb duplication from 2q11.1 to 2q11.2. Chromosomal microarray analysis (CMA) was performed on uncultured amniocytes. GTG-banding karyotype analysis on cultured amniocytes was performed. Chromosomal GTG-banding of the cultured amniocytes revealed a karyotype of 46,XX. CMA detected a 6.8-Mb chromosomal duplication in the region of 2q11.1q11.2 (arr[GRCh37] 2q11.1q11.2(95,327,873_102,088,148)x3). Chromosomal microdeletions and microduplications are difficult to detect by conventional cytogenetics, combination of prenatal ultrasound, karyotype analysis, NIPT, CMA and genetic counseling is helpful for the prenatal diagnosis of UBCA and chromosomal microdeletions/microduplications.
- 15 August 2022
- Published by Springer Nature in Molecular Cytogenetics
- Vol. 15 (1) , 1-5
Open AccessPrenatal diagnosis and genetic counseling of an inherited unbalanced chromosome abnormalities in a Chinese family
Unbalanced chromosome abnormalities (UBCA) are either gains or losses or large genomic regions, but the affected person is not or only minimally clinically affected. Copy number variants (CNVs) are an important source of normal and pathogenic genome variations. CNVs and UBCA identified in prenatal cases need careful considerations and correct interpretation if those are harmless or harmful variants from the norm. A 25-year-old, gravida 1, para 0, woman underwent amniocentesis at 18 weeks of gestation because the noninvasive prenatal testing (NIPT) results revealed a 6.8 Mb duplication from 2q11.1 to 2q11.2. Chromosomal microarray analysis (CMA) was performed on uncultured amniocytes. GTG-banding karyotype analysis on cultured amniocytes was performed. Chromosomal GTG-banding of the cultured amniocytes revealed a karyotype of 46,XX. CMA detected a 6.8-Mb chromosomal duplication in the region of 2q11.1q11.2 (arr[GRCh37] 2q11.1q11.2(95,327,873_102,088,148)x3). Chromosomal microdeletions and microduplications are difficult to detect by conventional cytogenetics, combination of prenatal ultrasound, karyotype analysis, NIPT, CMA and genetic counseling is helpful for the prenatal diagnosis of UBCA and chromosomal microdeletions/microduplications.
- 27 July 2022
- Published by IOP Publishing in Smart Materials and Structures
- Vol. 31 (9) , 099501
Corrigendum: Performance of Fe–Ga alloy rotational vibration energy harvester with centrifugal softening (2022 Smart Mater. Struct. 31 065008)
- 27 July 2022
- Published by IOP Publishing in Smart Materials and Structures
- Vol. 31 (9) , 099501
Corrigendum: Performance of Fe–Ga alloy rotational vibration energy harvester with centrifugal softening (2022 Smart Mater. Struct. 31 065008)
- Open Access
- 15 September 2021
- Published by Wiley in Journal of Diabetes Research
- Vol. 2021, 1-9
KLF4 Promotes Diabetic Chronic Wound Healing by Suppressing Th17 Cell Differentiation in an MDSC-Dependent Manner
Objectives. Diabetic wound inflammation deficiencies lead to ulcer development and eventual amputation and disability. Our previous research demonstrates that myeloid-derived suppressor cells (MDSCs) accumulate during inflammation and promote chronic wound healing via the regulation of Kruppel-like factor 4 (KLF4). In this study, we aimed to investigate the potential roles of MDSCs and KLF4 in diabetic wound healing. Methods. An ob/ob mouse pressure ulcer (PU) model was used to evaluate the process of wound healing. The expression levels of KLF4 and IL-17A were measured by real-time PCR, and the population of MDSCs and Th17 cells was measured by flow cytometry. The levels of cytokines were determined by an immunosuppression assay. Results. KLF4 deficiency in the diabetic PU model resulted in decreased accumulation of MDSCs, increased expansion of Th17 cells, and significantly delayed wound healing. Conversely, KLF4 activation by APTO-253 accelerated wound healing accompanied by increased MDSC populations and decreased numbers of Th17 cells. MDSCs have been proven to mediate Th17 differentiation via cytokines, and our in vitro data showed that elevated KLF4 expression in MDSCs resulted in reduced Th17 cell numbers and, thus, decreased levels of cytokines indispensable for Th17 differentiation. Conclusions. Our study revealed a previously unreported function of KLF4-regulated MDSCs in diabetic wound healing and identified APTO-253 as a potential agent to improve the healing of pressure ulcers.
- 15 September 2021
- Published by Wiley in Journal of Diabetes Research
- Vol. 2021, 1-9
Open AccessKLF4 Promotes Diabetic Chronic Wound Healing by Suppressing Th17 Cell Differentiation in an MDSC-Dependent Manner
Objectives. Diabetic wound inflammation deficiencies lead to ulcer development and eventual amputation and disability. Our previous research demonstrates that myeloid-derived suppressor cells (MDSCs) accumulate during inflammation and promote chronic wound healing via the regulation of Kruppel-like factor 4 (KLF4). In this study, we aimed to investigate the potential roles of MDSCs and KLF4 in diabetic wound healing. Methods. An ob/ob mouse pressure ulcer (PU) model was used to evaluate the process of wound healing. The expression levels of KLF4 and IL-17A were measured by real-time PCR, and the population of MDSCs and Th17 cells was measured by flow cytometry. The levels of cytokines were determined by an immunosuppression assay. Results. KLF4 deficiency in the diabetic PU model resulted in decreased accumulation of MDSCs, increased expansion of Th17 cells, and significantly delayed wound healing. Conversely, KLF4 activation by APTO-253 accelerated wound healing accompanied by increased MDSC populations and decreased numbers of Th17 cells. MDSCs have been proven to mediate Th17 differentiation via cytokines, and our in vitro data showed that elevated KLF4 expression in MDSCs resulted in reduced Th17 cell numbers and, thus, decreased levels of cytokines indispensable for Th17 differentiation. Conclusions. Our study revealed a previously unreported function of KLF4-regulated MDSCs in diabetic wound healing and identified APTO-253 as a potential agent to improve the healing of pressure ulcers.
- Open Access
- 31 May 2020
- Published by MDPI AG in Preprints.org
Risk Factors for Systemic and Venous Thromboembolism, Mortality and Bleeding Risks in 1125 Patients with COVID-19: Relationship to Anticoagulation Status
Coronavirus disease 2019 (COVID-19) has been associated with increased mortality and morbidity from thromboembolism, but with limit data on systemic thromboembolism. The present study aimed to investigate the prevalence of systemic and venous thromboembolism, as well as major bleeding and mortality, in relation to underlying risk factors and the impact of anticoagulation use in hospitalized patients with COVID-19. Patients with COVID-19 admitted to Union Hospital, Wuhan, Hubei, China between January 08, 2020 to April 7, 2020, were enrolled into the respective study. Cox proportional hazard models were utilised to determine associated risk factors for clinical events, adjusting for the severity of COVID-19 infection, drug therapies, comorbidities, surgery, and the use of antithrombotic drugs. There were 1125 patients (49.9% male; mean age 58 (standard deviation, SD, 15 years) with a mean follow-up of 21(SD13) days. Of these, 408(36.3%) were aged over 65 years, 33 (2.9%) underwent surgery, and 249(22.1%) received anticoagulants. Of the latter, 87(7.7%) received oral anticoagulants, 209(18.6%) parenteral anticoagulants, and 47(4.2%) received oral plus parenteral anticoagulants. There were 82(7.3%) thromboembolism events (37 systemic, 45 venous), 128(11.4%) major bleeding events, and 91(8.1%) deaths. About 25(30%) patients with thromboembolism also suffered bleeding events. Age was an independent risk factor for thromboembolism, bleeding events, and death (all p<0.05). After adjusting for the severity of COVID-19 infection, comorbidities, surgery, antiviral drugs, immunomodulators, Chinese herb, and antithrombotic drugs, low lymphocyte counts (hazard ratio, HR, 95% confidence interval (CI), 1.03, 1.01-1.05, p=0.01) and surgery (HR 2.80, 1.08-7.29, p=0.03) independently predicted the risk for major bleeding, while liver dysfunction ( HR 4.13, 1.30-13.1, p=0.02) was an independent risk factor for patients with both thromboembolism and bleeding events. Atrial fibrillation/ irregular rhythm increased the risk for systemic thromboembolism (HR 3.16, 1.06-9.46, p=0.04). Both oral anticoagulant (HR 0.32, 0.19-0.53) and parenteral anticoagulant (HR 0.39, 0.22-0.70) use reduced the risk for thromboembolism (all p<0.001). After adjustment, parenteral anticoagulant use had a borderline effect on both thromboembolism and bleeding events (0.36, 0.13-1.01, P=0.053), but significantly reduced the risk for the composite outcome of thromboembolism, bleeding events and death ((HR 0.70, 0.51-0.95, p=0.02). Patients with COVID-19 were at high risk for thromboembolic and bleeding events, as well as mortality. Anticoagulant use, especially parenteral anticoagulants significantly reduced the risk for composite outcome of thromboembolism, bleeding events and death. The presence of AF was a contributor to systemic thromboembolism in COVID-19 patients.
- 31 May 2020
- Published by MDPI AG in Preprints.org
Open AccessRisk Factors for Systemic and Venous Thromboembolism, Mortality and Bleeding Risks in 1125 Patients with COVID-19: Relationship to Anticoagulation Status
Coronavirus disease 2019 (COVID-19) has been associated with increased mortality and morbidity from thromboembolism, but with limit data on systemic thromboembolism. The present study aimed to investigate the prevalence of systemic and venous thromboembolism, as well as major bleeding and mortality, in relation to underlying risk factors and the impact of anticoagulation use in hospitalized patients with COVID-19. Patients with COVID-19 admitted to Union Hospital, Wuhan, Hubei, China between January 08, 2020 to April 7, 2020, were enrolled into the respective study. Cox proportional hazard models were utilised to determine associated risk factors for clinical events, adjusting for the severity of COVID-19 infection, drug therapies, comorbidities, surgery, and the use of antithrombotic drugs. There were 1125 patients (49.9% male; mean age 58 (standard deviation, SD, 15 years) with a mean follow-up of 21(SD13) days. Of these, 408(36.3%) were aged over 65 years, 33 (2.9%) underwent surgery, and 249(22.1%) received anticoagulants. Of the latter, 87(7.7%) received oral anticoagulants, 209(18.6%) parenteral anticoagulants, and 47(4.2%) received oral plus parenteral anticoagulants. There were 82(7.3%) thromboembolism events (37 systemic, 45 venous), 128(11.4%) major bleeding events, and 91(8.1%) deaths. About 25(30%) patients with thromboembolism also suffered bleeding events. Age was an independent risk factor for thromboembolism, bleeding events, and death (all p<0.05). After adjusting for the severity of COVID-19 infection, comorbidities, surgery, antiviral drugs, immunomodulators, Chinese herb, and antithrombotic drugs, low lymphocyte counts (hazard ratio, HR, 95% confidence interval (CI), 1.03, 1.01-1.05, p=0.01) and surgery (HR 2.80, 1.08-7.29, p=0.03) independently predicted the risk for major bleeding, while liver dysfunction ( HR 4.13, 1.30-13.1, p=0.02) was an independent risk factor for patients with both thromboembolism and bleeding events. Atrial fibrillation/ irregular rhythm increased the risk for systemic thromboembolism (HR 3.16, 1.06-9.46, p=0.04). Both oral anticoagulant (HR 0.32, 0.19-0.53) and parenteral anticoagulant (HR 0.39, 0.22-0.70) use reduced the risk for thromboembolism (all p<0.001). After adjustment, parenteral anticoagulant use had a borderline effect on both thromboembolism and bleeding events (0.36, 0.13-1.01, P=0.053), but significantly reduced the risk for the composite outcome of thromboembolism, bleeding events and death ((HR 0.70, 0.51-0.95, p=0.02). Patients with COVID-19 were at high risk for thromboembolic and bleeding events, as well as mortality. Anticoagulant use, especially parenteral anticoagulants significantly reduced the risk for composite outcome of thromboembolism, bleeding events and death. The presence of AF was a contributor to systemic thromboembolism in COVID-19 patients.
- 24 March 2020
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 26, e921063
Efficacy of Eutectic Mixture of Local Anesthetics on Pain Control During Extracorporeal Shock Wave Lithotripsy: A Systematic Review and Meta-Analysis
Background: The efficacy of a eutectic mixture of local anesthetics (EMLA) for pain control in extracorporeal shock wave lithotripsy is unclear. The aim of this study was to assess the effect of EMLA cream on pain control during extracorporeal shock wave lithotripsy. Material/Methods: We searched Medline, EMBASE, and the Cochrane Central Register of Controlled Trials to identify relevant randomized controlled trials that compared the pain control efficacies of EMLA vs. placebo. Study eligibility criteria, participants, and interventions: Randomized controlled trials that compared the effect of EMLA with placebo cream for patients underwent extracorporeal shock wave lithotripsy. Study appraisal and synthesis methods: Two review authors extracted data independently using a designed data extraction form and risk of bias by Cochrane Collaboration's tool. Results: Nine studies, including 10 randomized controlled trials with 1167 patients, were eligible. The EMLA group experienced less pain (mean difference, -0.47; 95% confidence interval, -0.78 to -0.16; p=0.003) and shorter duration of lithotripsy (mean difference, -1.70, 95% confidence interval: -2.31 to -1.10, p<0.0001) than the placebo group. There were no significant differences in the number of patients who needed extra intravenous medication (p=0.610), number of patients with insufficient extracorporeal shock wave lithotripsy pain control (p=0.530), and number of patients with opioid adverse effects (p=0.320). Limitations: Long interval between the studies, different kinds of lithotripters. Conclusions: EMLA can reduce pain during the ESWL procedure.
- 24 March 2020
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 26, e921063
Efficacy of Eutectic Mixture of Local Anesthetics on Pain Control During Extracorporeal Shock Wave Lithotripsy: A Systematic Review and Meta-Analysis
Background: The efficacy of a eutectic mixture of local anesthetics (EMLA) for pain control in extracorporeal shock wave lithotripsy is unclear. The aim of this study was to assess the effect of EMLA cream on pain control during extracorporeal shock wave lithotripsy. Material/Methods: We searched Medline, EMBASE, and the Cochrane Central Register of Controlled Trials to identify relevant randomized controlled trials that compared the pain control efficacies of EMLA vs. placebo. Study eligibility criteria, participants, and interventions: Randomized controlled trials that compared the effect of EMLA with placebo cream for patients underwent extracorporeal shock wave lithotripsy. Study appraisal and synthesis methods: Two review authors extracted data independently using a designed data extraction form and risk of bias by Cochrane Collaboration's tool. Results: Nine studies, including 10 randomized controlled trials with 1167 patients, were eligible. The EMLA group experienced less pain (mean difference, -0.47; 95% confidence interval, -0.78 to -0.16; p=0.003) and shorter duration of lithotripsy (mean difference, -1.70, 95% confidence interval: -2.31 to -1.10, p<0.0001) than the placebo group. There were no significant differences in the number of patients who needed extra intravenous medication (p=0.610), number of patients with insufficient extracorporeal shock wave lithotripsy pain control (p=0.530), and number of patients with opioid adverse effects (p=0.320). Limitations: Long interval between the studies, different kinds of lithotripters. Conclusions: EMLA can reduce pain during the ESWL procedure.
- Open Access
- 1 December 2019
- Published by Elsevier in Cell Reports
- Vol. 29 (12) , 4010-4023.e5
Induction of an Alternative mRNA 5′ Leader Enhances Translation of the Ciliopathy Gene Inpp5e and Resistance to Oncolytic Virus Infection
- 1 December 2019
- Published by Elsevier in Cell Reports
- Vol. 29 (12) , 4010-4023.e5
Open AccessInduction of an Alternative mRNA 5′ Leader Enhances Translation of the Ciliopathy Gene Inpp5e and Resistance to Oncolytic Virus Infection
- 21 February 2019
- Published by Maad Rayan Publishing Company
- Vol. 16 (1) , 21-26
Chinese One-shot Dilation versus Sequential Fascial Dilation for Percutaneous Nephrolithotomy: A Feasibility Study and Comparison
Purpose: Nephrostomy tract creation is a key step to perform a successful percutaneous nephrolithotomy (PCNL). In an attempt to improve the conventional technique of the tract dilation, a Chinese one-shot dilation was developed and compared with the sequential fascial dilation using a retrospective study. Materials and Methods: We retrospectively reviewed medical records of 116 patients who had undergone 116 PCNL in our department from January 2012 to December 2012. The nephrostomy tracts had been created by using Chinese one-shot (one-shot group, 59 cases) or sequential fascial dilation technique (sequential group, 57 cases). Tract creation time, hemorrhage loss, overall renal function, tract dilation failure and major complications were compared between the two groups. Results: The one-shot group had a significantly shorter mean (SD) tract creation time (1.9 +/- 0.5 vs 4.5 +/- 0.8 min, P < 0.001) and lower mean (SD) decrease in hemoglobin concentration (0.60 +/- 0.34 vs 0.69 +/- 0.36 g/dL, P = 0.0008) compared to the sequential group, respectively. There were no significant differences in mean (SD) value changes of preoperative and postoperative serum creatinine concentrations (4.7 +/- 11.5 vs 4.8 +/- 14.8 mu mol/L, P = 0.2611) and stone-free rate (86.4% vs 85.9%, P = 0.6145) between the one-shot and sequential group. No tract dilation failure or major complications occurred in both of the groups. Conclusion: This retrospective study demonstrated that the Chinese one-shot dilation technique is as safe and feasible as the conventional sequential fascial dilation. Furthermore, a greater reduction in tract creation time and blood loss was achieved using this technique.
- 21 February 2019
- Published by Maad Rayan Publishing Company
- Vol. 16 (1) , 21-26
Chinese One-shot Dilation versus Sequential Fascial Dilation for Percutaneous Nephrolithotomy: A Feasibility Study and Comparison
Purpose: Nephrostomy tract creation is a key step to perform a successful percutaneous nephrolithotomy (PCNL). In an attempt to improve the conventional technique of the tract dilation, a Chinese one-shot dilation was developed and compared with the sequential fascial dilation using a retrospective study. Materials and Methods: We retrospectively reviewed medical records of 116 patients who had undergone 116 PCNL in our department from January 2012 to December 2012. The nephrostomy tracts had been created by using Chinese one-shot (one-shot group, 59 cases) or sequential fascial dilation technique (sequential group, 57 cases). Tract creation time, hemorrhage loss, overall renal function, tract dilation failure and major complications were compared between the two groups. Results: The one-shot group had a significantly shorter mean (SD) tract creation time (1.9 +/- 0.5 vs 4.5 +/- 0.8 min, P < 0.001) and lower mean (SD) decrease in hemoglobin concentration (0.60 +/- 0.34 vs 0.69 +/- 0.36 g/dL, P = 0.0008) compared to the sequential group, respectively. There were no significant differences in mean (SD) value changes of preoperative and postoperative serum creatinine concentrations (4.7 +/- 11.5 vs 4.8 +/- 14.8 mu mol/L, P = 0.2611) and stone-free rate (86.4% vs 85.9%, P = 0.6145) between the one-shot and sequential group. No tract dilation failure or major complications occurred in both of the groups. Conclusion: This retrospective study demonstrated that the Chinese one-shot dilation technique is as safe and feasible as the conventional sequential fascial dilation. Furthermore, a greater reduction in tract creation time and blood loss was achieved using this technique.